Overview
Status
Active
Registry date
2022-05-19
Share capital
20 005 000,00 PLN
Registered address
ul. Kwidzyńska 6, 51-416 Wrocław, Poland
Electronic delivery address
AE:PL-17745-73406-TCUIE-26
Financials
Revenue history (in m)
Data and insights are generated automatically based on financial statements and may contain errors. This analysis is for informational purposes only and does not constitute an official assessment of the company's credibility or business advice.
Statistics
How the company ranks by revenue within its industry, region and across Poland in 2025.
Results vs industry
Revenue
This companyUSD 107.83mMedianUSD 816.16kAverageUSD 29.28m
Net profit
This companyUSD 5.22mMedianUSD 8.96kAverageUSD 2.64m
Operating costs
This companyUSD 97.49mMedianUSD 701.47kAverageUSD 19.26m
Assets
This companyUSD 189.30mMedianUSD 800.13kAverageUSD 29.34m
Industry
Bank accounts
Registered as a VAT taxpayer on 2022-06-03. Active
10 1030 1508 0000 0008 2334 2000
15 1030 1508 0000 0008 2334 2007
26 1030 1508 0000 0008 2334 2003
Debt
No entries in the National Debtors Register (KRZ). No proceedings in KRZ
MSiG notices
| Publication date | Event | |
|---|---|---|
| Nov 10, 2023 | Commercial Companies Code notice |
Public aid
No public aid cases recorded in the last 10 years.
Tenders
No recorded participation in tenders.
Authorized Representatives
Anna Barbara Maruszewska — Attorney-in-fact (sole)
Justyna Lidia Bielewicz — Attorney-in-fact (sole)
Krzysztof Bober — Management Board Member
Łukasz Stanisław Ostek — Attorney-in-fact (sole)
Manner of representation
A member of the management board acting independently is authorized to represent the company.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 400,100 | $5,403,835.76 | 100% |
Beneficial owners
| Person | Rights | |
|---|---|---|
Krzysztof Bober (58) | Natural person holding a senior management position (AML Act art. 2(2)(1)(a) indent 5). |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Przedsiębiorstwo Produkcji Farmaceutycznej Hasco - LekS.A. | $119,621,017.71 | hasco-lek.pl | ||
| Delpharm PoznańS.A. | $110,900,246.81 | delpharm.com | ||
| Wrocławskie Zakłady Zielarskie HerbapolS.A. | $46,537,868.51 | herbapol.pl | ||
| Labor Przedsiębiorstwo Farmaceutyczno - Chemicznesp. z o.o. | $1,184,204.34 | labor.com.pl | ||
| Zeptor Polskasp. z o.o. | $748,374.79 | zeptor.pl | ||
| STEM Cells SpinS.A. | $287,714.76 | stemcellsspin.com.pl | ||
| LideoS.A. | $95,067.91 | lideo.tech | ||
| BIO Animalisp. z o.o. | $49,176.96 | proanimali.com | ||
| Ampliconsp. z o.o. | $48,330.99 | amplicon.pl | ||
| Xenira Pharmaceuticalssp. z o.o. | $26,670.82 | xenirapharma.com |
Change history
| Date | Event | |
|---|---|---|
| 2024-07-24 | Name change (3m Healthcare Poland Manufacturing → Solventum Poland Manufacturing) | |
| 2023-11-02 | Share capital change (5,000.00 PLN → 20,005,000.00 PLN) | |
| 2023-05-26 | Address change (Ul. Grzybowska 2/29, 00-131, Warszawa → Ul. Kwidzyńska 6, 51-416, Wrocław) | |
| 2023-05-26 | Name change (Ghisalba → 3m Healthcare Poland Manufacturing) | |
| 2023-05-26 | PKD change (Removed: 41, 62, 63, 68, 70.22.Z, 73, 74, 78, 82, 96; Added: 13.92.Z, 20.41.Z, 20.42.Z, 20.59.Z, 21.20.Z, 22.29.Z, 32.50.Z, 32.99.Z, 72.19.Z) |
FAQ
The main business activity of Solventum Poland Manufacturing focuses on manufacture of pharmaceutical preparations.
The company was registered in the Polish National Court Register (KRS) on May 19, 2022.
The headquarters is located at: ul. Kwidzyńska 6, 51-416 Wrocław.
The share capital of the company is PLN 20,005,000 (approx. $5.4 million).
The latest available financial statement covers the period from January 1, 2025 to December 31, 2025.
The company reported a revenue of $107,827,166 in 2025, which is an increase of 13.2% compared to 2024.
Yes, the company recorded a net profit of $5,215,184 in 2025, meaning the company decreased its profit by 36.0%.
The largest operating cost category falls under materials and energy. This category amounted to $53,474,337 in 2025, representing 55% of all operating expenses.
Last updated: 2026-06-11